Liver cirrhosis
Liver cirrhosis is a deadly condition in which MSC therapy has been shown to improve liver function, create a beneficial immune-environment, and increase survival rates
Key Insights
Improves liver function and quality of life: In a majority of studies MSC therapy leads to a significant improvement of liver function (measured by albumin, bilirubin etc) and quality of life in treated patients
Creates a beneficial immune-environment: Multiple trials shows that MSC therapy affects the immune system in a positive manner, some even shows that it achieves a better effect than immunosuppressants such as rituximab
Excellent Safety Profile: Of 756 patients treated no treatment associated adverse event is reported, the worst side-effect being fever after the cell infusion
Clinical Studies
Clinical trials